Improved in vivo delivery of small RNA based on the calcium phosphate method

7Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

Abstract

In the past few years, we have demonstrated the efficacy of a nanoparticle system, super carbonate apatite (sCA), for the in vivo delivery of siRNA/miRNA. Intravenous injection of sCA loaded with small RNAs results in safe, high tumor delivery in mouse models. To further improve the efficiency of tumor delivery and avoid liver toxicity, we successfully developed an inorganic nanoparticle device (iNaD) via high-frequency ultrasonic pulverization combined with PEG blending during the production of sCA. Compared to sCA loaded with 24 µg of miRNA, systemic administration of iNaD loaded with 0.75 µg of miRNA demonstrated similar delivery efficiency to mouse tumors with little accumulation in the liver. In the mouse therapeutic model, iNaD loaded with 3 µg of the tumor suppressor small RNA MIRTX resulted in an improved anti-tumor effect compared to sCA loaded with 24 µg. Our findings on the bio-distribution and therapeutic effect of iNaD provide new perspectives for future nanomedicine engineering.

Cite

CITATION STYLE

APA

Wu, X., Yokoyama, Y., Takahashi, H., Kouda, S., Yamamoto, H., Wang, J., … Yamamoto, H. (2021). Improved in vivo delivery of small RNA based on the calcium phosphate method. Journal of Personalized Medicine, 11(11). https://doi.org/10.3390/jpm11111160

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free